124 related articles for article (PubMed ID: 20219372)
1. Synthesis and SAR of derivatives based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.
Liu J; He S; Jian T; Dobbelaar PH; Sebhat IK; Lin LS; Goodman A; Guo C; Guzzo PR; Hadden M; Henderson AJ; Pattamana K; Ruenz M; Sargent BJ; Swenson B; Yet L; Tamvakopoulos C; Peng Q; Pan J; Kan Y; Palyha O; Kelly TM; Guan XM; Howard AD; Marsh DJ; Metzger JM; Reitman ML; Wyvratt MJ; Nargund RP
Bioorg Med Chem Lett; 2010 Apr; 20(7):2074-7. PubMed ID: 20219372
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR of heterocyclic carboxylic acid isosteres based on 2-biarylethylimidazole as bombesin receptor subtype-3 (BRS-3) agonists for the treatment of obesity.
Hadden M; Goodman A; Guo C; Guzzo PR; Henderson AJ; Pattamana K; Ruenz M; Sargent BJ; Swenson B; Yet L; Liu J; He S; Sebhat IK; Lin LS; Tamvakopoulos C; Peng Q; Kan Y; Palyha O; Kelly TM; Guan XM; Metzger JM; Reitman ML; Nargund RP
Bioorg Med Chem Lett; 2010 May; 20(9):2912-5. PubMed ID: 20347296
[TBL] [Abstract][Full Text] [Related]
3. Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists.
He S; Dobbelaar PH; Liu J; Jian T; Sebhat IK; Lin LS; Goodman A; Guo C; Guzzo PR; Hadden M; Henderson AJ; Ruenz M; Sargent BJ; Yet L; Kelly TM; Palyha O; Kan Y; Pan J; Chen H; Marsh DJ; Shearman LP; Strack AM; Metzger JM; Feighner SD; Tan C; Howard AD; Tamvakopoulos C; Peng Q; Guan XM; Reitman ML; Patchett AA; Wyvratt MJ; Nargund RP
Bioorg Med Chem Lett; 2010 Mar; 20(6):1913-7. PubMed ID: 20167483
[TBL] [Abstract][Full Text] [Related]
4. Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonist.
Guan XM; Metzger JM; Yang L; Raustad KA; Wang SP; Spann SK; Kosinski JA; Yu H; Shearman LP; Faidley TD; Palyha O; Kan Y; Kelly TM; Sebhat I; Lin LS; Dragovic J; Lyons KA; Craw S; Nargund RP; Marsh DJ; Strack AM; Reitman ML
J Pharmacol Exp Ther; 2011 Feb; 336(2):356-64. PubMed ID: 21036912
[TBL] [Abstract][Full Text] [Related]
5. Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.
Metzger JM; Gagen K; Raustad KA; Yang L; White A; Wang SP; Craw S; Liu P; Lanza T; Lin LS; Nargund RP; Guan XM; Strack AM; Reitman ML
Am J Physiol Endocrinol Metab; 2010 Nov; 299(5):E816-24. PubMed ID: 20807840
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 7-benzyl-5-(piperidin-1-yl)-6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c][2,7]naphthyridin-1-ylamine and its analogs as bombesin receptor subtype-3 agonists.
Guo C; Guzzo PR; Hadden M; Sargent BJ; Yet L; Kan Y; Palyha O; Kelly TM; Guan X; Rosko K; Gagen K; Metzger JM; Dragovic J; Lyons K; Lin LS; Nargund RP
Bioorg Med Chem Lett; 2010 May; 20(9):2785-9. PubMed ID: 20371178
[TBL] [Abstract][Full Text] [Related]
7. Discovery of high affinity bombesin receptor subtype 3 agonists.
Wu JM; Nitecki DE; Biancalana S; Feldman RI
Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
[TBL] [Abstract][Full Text] [Related]
8. Appetite-modifying effects of bombesin receptor subtype-3 agonists.
Majumdar ID; Weber HC
Handb Exp Pharmacol; 2012; (209):405-32. PubMed ID: 22249826
[TBL] [Abstract][Full Text] [Related]
9. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
Fong TM; Guan XM; Marsh DJ; Shen CP; Stribling DS; Rosko KM; Lao J; Yu H; Feng Y; Xiao JC; Van der Ploeg LH; Goulet MT; Hagmann WK; Lin LS; Lanza TJ; Jewell JP; Liu P; Shah SK; Qi H; Tong X; Wang J; Xu SS; Francis B; Strack AM; MacIntyre DE; Shearman LP
J Pharmacol Exp Ther; 2007 Jun; 321(3):1013-22. PubMed ID: 17327489
[TBL] [Abstract][Full Text] [Related]
10. Regulation of energy homeostasis by bombesin receptor subtype-3: selective receptor agonists for the treatment of obesity.
Guan XM; Chen H; Dobbelaar PH; Dong Y; Fong TM; Gagen K; Gorski J; He S; Howard AD; Jian T; Jiang M; Kan Y; Kelly TM; Kosinski J; Lin LS; Liu J; Marsh DJ; Metzger JM; Miller R; Nargund RP; Palyha O; Shearman L; Shen Z; Stearns R; Strack AM; Stribling S; Tang YS; Wang SP; White A; Yu H; Reitman ML
Cell Metab; 2010 Feb; 11(2):101-12. PubMed ID: 20096642
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
[TBL] [Abstract][Full Text] [Related]
12. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
[TBL] [Abstract][Full Text] [Related]
13. Biology and pharmacology of bombesin receptor subtype-3.
Majumdar ID; Weber HC
Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):3-7. PubMed ID: 22157398
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and activity of 4,5-diarylimidazoles as human CB1 receptor inverse agonists.
Plummer CW; Finke PE; Mills SG; Wang J; Tong X; Doss GA; Fong TM; Lao JZ; Schaeffer MT; Chen J; Shen CP; Stribling DS; Shearman LP; Strack AM; Van der Ploeg LH
Bioorg Med Chem Lett; 2005 Mar; 15(5):1441-6. PubMed ID: 15713403
[TBL] [Abstract][Full Text] [Related]
15. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
Mantey SA; Coy DH; Entsuah LK; Jensen RT
J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
[TBL] [Abstract][Full Text] [Related]
16. Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.
Yan L; Huo P; Debenham JS; Madsen-Duggan CB; Lao J; Chen RZ; Xiao JC; Shen CP; Stribling DS; Shearman LP; Strack AM; Tsou N; Ball RG; Wang J; Tong X; Bateman TJ; Reddy VB; Fong TM; Hale JJ
J Med Chem; 2010 May; 53(10):4028-37. PubMed ID: 20423086
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 2-[5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice.
Wu CH; Hung MS; Song JS; Yeh TK; Chou MC; Chu CM; Jan JJ; Hsieh MT; Tseng SL; Chang CP; Hsieh WP; Lin Y; Yeh YN; Chung WL; Kuo CW; Lin CY; Shy HS; Chao YS; Shia KS
J Med Chem; 2009 Jul; 52(14):4496-510. PubMed ID: 19530697
[TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
[TBL] [Abstract][Full Text] [Related]
19. The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization.
Chobanian HR; Guo Y; Liu P; Lanza TJ; Chioda M; Chang L; Kelly TM; Kan Y; Palyha O; Guan XM; Marsh DJ; Metzger JM; Raustad K; Wang SP; Strack AM; Gorski JN; Miller R; Pang J; Lyons K; Dragovic J; Ning JG; Schafer WA; Welch CJ; Gong X; Gao YD; Hornak V; Reitman ML; Nargund RP; Lin LS
Bioorg Med Chem; 2012 May; 20(9):2845-9. PubMed ID: 22494842
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists.
Kiyotsuka Y; Shimada K; Kobayashi S; Suzuki M; Akiu M; Asano M; Sogawa Y; Hara T; Konishi M; Abe-Ohya R; Izumi M; Nagai Y; Yoshida K; Abe Y; Takamori H; Takahashi H
Bioorg Med Chem Lett; 2016 Sep; 26(17):4205-10. PubMed ID: 27491709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
